The EVERY Company

Launching the world’s first company to grow eggs from cell cultures instead of hens

2014

Overview

For decades, humanity has produced high value, small volume proteins, enzymes, and small molecules via cell cultures. What if we leveraged decades of experience in industrial fermentation to produce egg proteins this way?

That is exactly what New Harvest community members Arturo Elizondo and David Anchel set out to do as the New Harvest Egg Project.

The New Harvest Egg Project eventually turned into Clara Foods (now The EVERY Company), the world’s first company to grow egg whites from cell cultures instead of hens.

Behind-the-scenes

At the beginning of The EVERY Company’s journey, we documented updates about the project here.

The EVERY Company is now too big for us to keep track of what they’re up to. They are also an independent company! To stay up-to-date on The EVERY Company’s latest developments, please visit their website.

: The EVERY Company’s hen-free egg white meringue

: David holding a yeast culture capable of producing egg white proteins.

Updates

October, 2021 – Clara Foods rebrands as The EVERY Company.

February, 2015 – New Harvest publishes an interview with Arturo and an interview with David.

March, 2015 – In light of growing independent interest among investors in cellular agriculture, New Harvest moves away from founding companies. Instead, we focus on more neglected aspects of ecosystem building and supporting pre-competitive research.

December, 2014 – The New Harvest Egg Project is renamed Clara Foods and accepted into IndieBio SF, an accelerator which provides lab space and funding.

November, 2014 – David Anchel, Arturo Elizondo, and New Harvest unite as the New Harvest Egg Project.

See More Initiatives

2022 - Present

CMSI Phase II: International Regulatory and Government Perspectives

The Cultured Meat Safety Initiative (CMSI) is a joint initiative between New Harvest and Vireo Advisors aiming to address critical technical, methodological, and informational challenges related to evaluating the safety of cultured meat (CM) products.

CMSI involves the convening of diverse stakeholders, including industry, governmental scientists, regulators, academic researchers, and others. Gaining such varied perspectives advances public knowledge and the practice of food safety for CM products by identifying and addressing data gaps. Research conducted to develop data and methods build the necessary support elements for the emerging ecosystem, which can raise regulatory and consumer confidence, support industry efforts toward commercialization, and improve the efficacy of evaluation processes of regulatory safety reviews.

Building on progress from Phase I of the Cultured Meat Safety Initiative (CMSI), New Harvest and Vireo Advisors convened governmental scientists and regulators from 15 jurisdictions around the world to identify governmental priorities for the safety methods, data, and research needed to support safety evaluation of cultured meat products to reach commercial markets worldwide.

2020 - PRESENT

The New Harvest OpenCellAg Repository

In order to see our vision of a more just, equitable, and humane food system one of our key strategies is to default to open. By creating an open cellular agriculture repository on Zenodo we ensure that the research produced by New Harvest and other researchers is accessible for all to use, read, share, and build upon. In that way we are increasing the impact of this crucial knowledge by furthering its reach.

2020 - Present

CMSI Phase I: Safety Roadmap for Cultured Meat

The Cultured Meat Safety Initiative (CMSI), a joint initiative between New Harvest and Vireo Advisors aiming to address critical technical, methodological, and informational challenges related to evaluating the safety of cultured meat (CM).

This involves the convening of diverse stakeholders, including industry, governmental scientists, regulators, academic researchers, and consumers. Gaining such varied perspectives advances public knowledge and the practice of food safety for CM products by identifying and addressing data gaps. Research conducted to develop data and methods build the necessary support elements for the emerging ecosystem, which can raise regulatory and consumer confidence, support industry efforts toward commercialization, and improve the evaluation processes of regulatory safety reviews.

Because growing meat through cell culture is so novel a process, many questions about the safety of cell-cultured meat and seafood products remain unanswered.

This industry-wide initiative was designed in partnership with Vireo Advisors to begin a data-driven conversation about the safety of cultured meat.

Fifty cultured meat companies shared previously unpublished details about their manufacturing processes which we used to create a body of publicly available information about how cultured meat is produced and what safety hazards might be introduced along the way.